Cargando…
Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study
Ductal carcinoma in situ (DCIS) of the breast is a non-obligate precursor of Invasive Ductal Carcinoma (IDC) and thus the identification of features that may predict DCIS progression would be of potential clinical value. Experimental mouse models can be used to address this challenge by studying DCI...
Autores principales: | Thennavan, Aatish, Garcia-Recio, Susana, Liu, Siyao, He, Xiaping, Perou, Charles M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293914/ https://www.ncbi.nlm.nih.gov/pubmed/35851387 http://dx.doi.org/10.1038/s41523-022-00450-w |
Ejemplares similares
-
MultiK: an automated tool to determine optimal cluster numbers in single-cell RNA sequencing data
por: Liu, Siyao, et al.
Publicado: (2021) -
Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020) -
Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness
por: Zheng, Ze-Yi, et al.
Publicado: (2022) -
Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002) -
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
por: Herschkowitz, Jason I, et al.
Publicado: (2008)